tiprankstipranks
Trending News
More News >
Dlaboratory Sweden AB (SE:DLAB)
:DLAB

Dlaboratory Sweden AB (DLAB) AI Stock Analysis

Compare
0 Followers

Top Page

SE:DLAB

Dlaboratory Sweden AB

(DLAB)

Select Model
Select Model
Select Model
Neutral 47 (OpenAI - 5.2)
,
Neutral 47 (OpenAI - 5.2)
,
Neutral 47 (OpenAI - 5.2)
Rating:47Neutral
Price Target:
kr2.00
▼(-13.04% Downside)
Action:ReiteratedDate:03/02/26
The score is primarily held back by weak financial performance—continued losses, negative EBIT/EBITDA, and negative gross profit in 2025—despite low leverage and a one-year improvement to positive operating cash flow. Technicals are neutral-to-slightly supportive with price near/above key averages, but valuation lacks support given negative earnings and no dividend data.
Positive Factors
Low leverage / near-zero debt
Very low debt materially reduces refinancing and interest-rate risk and provides balance-sheet resilience. Over the next 2–6 months this structural conservatism gives the company flexibility to prioritize operational recovery, fund selective investments, or endure volatility without immediate financing pressure.
Operating cash flow turned positive in 2025
A shift to positive operating cash flow is a meaningful structural improvement if sustained: it signals operational discipline and reduces dependency on external funding. Over a multi-month horizon repeatable cash generation can support working capital and modest capex while stabilizing liquidity dynamics.
Revenue scaled materially since 2020
Revenue growth since 2020 indicates prior market traction and product/service demand. That established top-line scale provides a durable foundation to rebuild margins and regain growth, assuming management fixes cost structure; this structural customer/market presence helps recovery prospects over months.
Negative Factors
Persistent net losses and negative EBITDA
Sustained multi-year operating losses and negative EBITDA indicate structural unprofitability and ongoing cash burn. Over a 2–6 month horizon this undermines reinvestment capacity, erodes stakeholder confidence, and means any recovery must overcome entrenched margin deficiencies to become self-sustaining.
2025 gross profit turned negative
Negative gross profit implies the company is losing money on core goods/services, reflecting broken unit economics or severe cost pressures. This structural problem cannot be fixed by SG&A cuts alone; it requires pricing, supply, or mix changes to restore fundamental profitability over the medium term.
Eroding equity / shrinking capital base
A sharply reduced equity base limits financial flexibility and the ability to absorb further losses or finance growth organically. Even with low debt, depleted equity raises the likelihood of needing external capital, which can dilute shareholders or constrain strategic options over the coming months.

Dlaboratory Sweden AB (DLAB) vs. iShares MSCI Sweden ETF (EWD)

Dlaboratory Sweden AB Business Overview & Revenue Model

Company DescriptionDlaboratory Sweden AB (publ) operates as a cleantech company in Sweden. It provides dInsight Analytics platform that connects and collects grid data; analyses to unlock critical information; categorizes and visualizes; and transform the information in meaningful context and actionable knowledge. The company was incorporated in 2010 and is based in Lund, Sweden.

Dlaboratory Sweden AB Financial Statement Overview

Summary
Despite materially higher revenue versus 2020, performance has deteriorated recently (revenue down ~17% in 2025). Profitability is a major weakness with persistent net losses, consistently negative EBIT/EBITDA, and 2025 gross profit turning negative. The balance sheet is conservatively levered (near-zero debt), and operating cash flow turned positive in 2025, but cash flow has been volatile and equity has fallen sharply over time.
Income Statement
18
Very Negative
Revenue has scaled materially versus 2020, but the growth path has turned inconsistent recently (down ~17% in 2025 after modest growth in 2024). Profitability remains weak: the company has reported net losses every year from 2020–2025, with EBIT and EBITDA consistently negative. A key red flag is 2025 gross profit turning negative, suggesting sharp cost pressure or adverse mix changes, and it keeps the business far from sustainable earnings power despite earlier periods showing strong gross margins.
Balance Sheet
52
Neutral
Leverage is very conservative (debt is near-zero by 2024–2025), which reduces refinancing risk and provides some balance-sheet resilience. However, equity has fallen sharply from 2021 to 2025, reflecting ongoing losses and limiting financial flexibility over time. Returns on equity have been deeply negative across the available years, and total assets have also trended down since 2021—signs of a shrinking capital base despite low debt.
Cash Flow
33
Negative
Cash generation has been volatile. Operating cash flow was significantly negative through 2020–2024, but turned positive in 2025, which is a constructive shift if it proves repeatable. Free cash flow has generally been negative when disclosed, and 2025 free cash flow is reported at 0, implying limited surplus cash after investments. Overall, cash flow quality is improving but not yet consistently strong enough to offset the history of cash burn.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue44.09M46.78M44.87M45.76M18.05M
Gross Profit-8.29M9.96M36.40M40.20M17.83M
EBITDA-5.94M-3.55M-8.38M-6.44M-14.23M
Net Income-7.65M-6.19M-11.05M-8.99M-16.13M
Balance Sheet
Total Assets20.82M24.65M30.62M37.97M48.20M
Cash, Cash Equivalents and Short-Term Investments5.65M5.74M10.53M14.71M28.16M
Total Debt0.000.00440.00K920.00K1.57M
Total Liabilities17.31M13.48M13.25M9.74M11.32M
Stockholders Equity3.52M11.17M17.37M28.23M36.87M
Cash Flow
Free Cash Flow0.00-3.08M-3.93M-13.15M-12.99M
Operating Cash Flow1.81M-3.08M-3.93M-13.15M-12.80M
Investing Cash Flow-1.88M-1.27M0.000.00-11.96M
Financing Cash Flow-12.00K-440.00K-248.00K-303.00K45.73M

Dlaboratory Sweden AB Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2.30
Price Trends
50DMA
2.50
Negative
100DMA
2.40
Negative
200DMA
2.38
Negative
Market Momentum
MACD
-0.06
Positive
RSI
34.29
Neutral
STOCH
16.67
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:DLAB, the sentiment is Negative. The current price of 2.3 is below the 20-day moving average (MA) of 2.45, below the 50-day MA of 2.50, and below the 200-day MA of 2.38, indicating a bearish trend. The MACD of -0.06 indicates Positive momentum. The RSI at 34.29 is Neutral, neither overbought nor oversold. The STOCH value of 16.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:DLAB.

Dlaboratory Sweden AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (66)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
66
Neutral
$17.65B18.105.60%3.62%6.62%11.55%
47
Neutral
kr37.62M-5.32-177.06%-4.02%6.77%
47
Neutral
kr195.08M-4.23-5.97%-100.00%31.68%
43
Neutral
kr127.66M-1.01-47.34%-36.89%33.50%
* Utilities Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:DLAB
Dlaboratory Sweden AB
2.22
-0.53
-19.27%
SE:CLIME.B
Climeon AB
2.50
-0.28
-10.11%
SE:MINEST
Minesto AB
0.75
-0.98
-56.75%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 02, 2026